Market Live: Sensex off opening high, Nifty breaks 10,100; Infosys, Biocon rally News News / News 7 years ago 685 Views comments Biocon surged 10 percent as the US FDA approved Mylan and Biocon#39;s Ogivri, the first biosimilar for Trastuzumab, for the Treatment of HER2-Positive... Read more
News VVIP choppers deal: CBI court issues warrants against European middlemen News / News - 7 years ago
News Debt-ridden farmer's daughter allegedly commits suicide in Maharashtra News / News - 7 years ago
Comments